Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Geen hogere mortaliteit COVID-19 bij NSAID-gebruik
jan 2021 | Artrose, RA, Virale infecties